CRBU LAWSUIT ALERT: Levi & Korsinsky Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want ...
NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimer’s Disease
The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse ...
manilatimes2d
INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer
The Scientific Review Committee (SRC) charter is to review the safety data from the patients treated in the Phase I portion ...
MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and ...
INmune Bio, Inc.: INmune Bio Opens Phase II in High Dose Cohort of INKmune Trial in Prostate Cancer
Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) -- INmune Bio ...
Nkarta, Inc. (NASDAQ:NKTX) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) have been assigned a consensus rating of “Buy” from the seven ...
Morningstar13d
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit
So what: If you purchased Caribou securities during the Class Period you ... research activities associated with the allogeneic CAR-NK platform; (3) the foregoing was likely to have a significant ...
LS forms Select Committee to examine new Income Tax Bill; Baijayant Panda appointed Chairperson
Om Birla, the Speaker of the Lok Sabha, has appointed a Select Committee under Baijayant Panda to scrutinize the Income-Tax ...
Aardvark Therapeutics Starts $100 Million IPO Effort For Hunger Treatments
Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...